Navidea Biopharmaceuticals (NAVB) Announces Fourth Quarter And Full Year 2013 Results
3/6/2014 7:26:24 AM
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced results for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.